Skip to content

The Clinical Content & Reuse (CC&R) Team announces their 2020 release!

The Clinical Content & Reuse (CC&R) initiative aims to enhance clinical trial processes by providing harmonized structure and proposed model content within clinical trial documents (e.g., Common Protocol Template, Statistical Analysis Plan, and Clinical Study Report) that can be reused throughout the project lifecycle to enable digitization and traceability through automation. The initiative’s guiding principles include a streamlined and consistent structure and content that can be used across multiple documents and processes, and is aligned with Good Clinical Practice (GCP), ICH and EU requirements, with elements drawn from Clarity and Openness in Reporting (CORE) Reference.

Our annual release continues to provide benefits to regulators, investigator sites, patients, and research sponsors. 

The 2020 release includes these key changes:

  1. Focus on Content Reuse: Updates to the implementation tools and CC&R website provide more focus on how the Clinical Template Suite (CTS) and tools enable content reuse across the clinical development ecosystem. 
  2. Updates to Template Content: CTS content enhancements have focused on alignment with ICH E9 (R1) estimands recommendations, registry ( content quality, and user-driven feedback on template clarity. 
  3. Updates to eTemplates: Updates to the eTemplates seek to minimize barriers to adoption by providing support/guidance on customizing libraries, aligning with content updates, and improving functionality to accommodate more complex trial designs.
  4. Enhanced Patient Centricity & Registration: In partnership with the Clinical Research Access & Information Exchange initiative, the Common Protocol Template is now integrated with the Clinical Trial Registration Tool to enable evaluation of the quality and patient friendly text of the brief title and brief summary data, and can now export 35+ data fields for automating quality registry submissions to

This year, the team is also excited to present an updated graphic that illustrates the interconnectedness, continued growth and development of the CC&R Initiative. Presented as three interconnected triangles, the image denotes the close relationships among the clinical template suite, harmonized model content and reuse capabilities. The initiative is grounded by its guiding principles and flexible implementation options.

Looking ahead, the team anticipates a busy 2021 as they will continue to make content enhancements, including enhancing eTemplates to minimize adoption barriers. They are also assessing adoption of new automation technologies, including a clinical trial registration tool and a export profile.

We welcome you to visit our updated CC&R initiative website and solutions page to learn more and we invite you to share your feedback on the Clinical Template Suite.

By Mark Makurath, Head of GCD Standards & Training Excellence at Merck

Related Blog Posts

Inspiring Inclusion: The Power of Pivotal Moments 

This year, TransCelerate honored International Women’s Day, and the theme of “inspiring inclusivity” by gathering a panel of distinguished thought leaders within biopharma R&D for a discussion on “Inspiring Inclusion: The Power of Pivotal Moments.”  TransCelerate COO Allison Cuff Shimooka moderated the event. Panelists were Esther Krofah (Milken Institute Health), Joni Rutter (NCATS/NIH), Janet Woodcock…

SCOPE Summit 2024: Modernizing and Personalizing Clinical Trials  

SCOPE 2024 kicked off with 4,000 attendees traveling to Orlando, Florida, for the much-anticipated event. Common themes shared across all sessions include the importance of collaboration, focusing on patients and their caregivers, and avoiding a “one size fits all” approach to designing clinical trials. Read on for the highlights from TransCelerate’s seven sessions.   The conference…